Two drug manufacturers asked the Supreme Court on Saturday to temporarily allow patients to continue to access a commonly used abortion pill through the mail.
Danco Laboratories filed the first emergency appeal after the U.S. Court of Appeals for the 5th Circuit in New Orleans issued a ruling Friday making it harder for women to access the abortion pill, mifepristone. Later Saturday, GenBioPro, which manufacturers a generic version of the drug, also formally requested the justices weigh in.
